文献库搜索 | GeneLibs

Demirkol(MO),Kaya(G),Seymen(H),Alagol(F),S... Clin Nucl Med 2026-05-01

...BRAF inhibition) followed by dosimetry-guided radioiodine therapy. Redifferentiation success was defined on post-rediffe...

Devoldere(A),Bouche(O),Barbe(C),Didier(K),... Melanoma Res 2026-04-01

In resected stage III BRAF V600-mutated melanoma, patients are eligible for adjuvant targeted therapy or immune checkpoi...

Yu(T),Hou(J),Zheng(L),Zhong(J),Pan(X),Zhan... Virchows Arch 2026-02-15

...BRAF translocations, while BRAF V600E mutations and non-BRAF alterations were more common in adults. Among 564 patients ...

Alqahtani(SM),Afzal(M),Afzal(O),Alabbas(A)... Clin Chim Acta 2026-04-01

...BRAF, NRAS, and TERT mutations using droplet digital PCR (ddPCR) and next-generation sequencing (NGS). Longitudinal ctDN...

McGrath(N),Liang(L),Bakkar(R),Gernon(TJ),M... Virchows Arch 2026-02-16

...BRAF, MTDH1::BRAF, ARHGAP26::BRAF, BRAF::STRBF, FCHSDH2::BRAF, BRAF::POM121C, UBAP2L::BRAF). In 3 PTCs, BRAF fusions wer...

Messing(I),Linkowski(L),Riina(MD),Berger(M... Oncologist 2026-03-09

...BRAF/MEKi (HR 2.26, 95% CI 1.01-5.04), and ≥11 SRS-treated lesions (HR 3.22, 95% CI 1.43-7.21) predicted worse outcomes,...

Akhavan(B),Samlowski(W) Front Immunol None

...BRAF mutation status, serum lactate dehydrogenase levels, PD-L1 expression, and tumor mutation burden were correlated wi...

Afonso(ARS),Salgueira(SG),Noya(R),Silva(J)... Cureus 2026-01-00

...BRAF wild-type status, supporting metastatic recurrence. The patient subsequently developed recurrent haemoptysis and wo...

Al-Bahlani(AQ),Touseeq(L),Al-Masqari(M),Sa... JPGN Rep 2026-02-00

...BRAF mutation analysis) in guiding therapy.

Salem(AE),Ramirez(S),Weston(BR),Hussein(A)... Front Med (Lausanne) None

...BRAF V600E-mutated papillary thyroid carcinoma (PTC) who developed persistent dysphagia following total thyroidectomy as...